1. 1632P_PRCharacterizing the risk of drug-drug interactions in sarcoma treated patients: Role of pharmacist integration. (23rd October 2018) Authors: Bellesoeur, A; Gataa, I; Jouinot, A; El Mershati, S; Arrondeau, J; Tlemsani, C; Blanchet, B; Alexandre, J; Goldwasser, F; Thomas-Schoemann, A; Boudou Rouquette, P Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 451PPharmacokinetic drug-drug interaction between mitotane and etoposide in the treatment of adrenocortical carcinoma. (23rd October 2018) Authors: Jouinot, A; Royer, B; Moeung, S; Chatelut, E; Bellesoeur, A; Assié, G; Thomas-Schoemann, A; Bertherat, J; Goldwasser, F; Blanchet, B Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. CP-240 The clinical pharmacist resolves medication relative problems in oncologic patients. is it true?. (25th February 2017) Authors: Borja-Prats, C; Conort, O; Maire, A; Jouinot, A; Thomas-Schoemann, A; Alexandre, J; Brandely, M; Batista, R; Bardin, C Journal: European journal of hospital pharmacy Issue: Volume 24(2017)Supplement 1 Page Start: A108 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗